Dr. Bo Chen 陈波
Chief Physician
Department of Radiation Oncology, Cancer Hospital, Chinese Academy of Medical Sciences (National Cancer Center), Beijing
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Radiation therapy and management of abdominal tumors, including liver, bile duct, pancreatic, lymphoma, breast, rectal, gastric, and prostate cancers.
Dr. Chen is a Chief Physician and doctoral supervisor at the Cancer Hospital, Chinese Academy of Medical Sciences. The doctor leads national research projects and has published prospective clinical studies in Hepatology, JAMA Surgery, and JHEP Reports. According to the hospital, Dr. Chen pioneered radiation techniques for hepatobiliary and pancreatic tumors, reporting 80-90% local efficacy for liver cancer with portal vein tumor thrombus or lymph node metastasis.
Name order: in Chinese the family name comes first (Chen Bo). Papers usually list the name as Bo Chen or Chen B.
Selected publications
149 papers on PubMed matched by name and affiliation; 10 as first or senior author since 2016. Most recent first- or senior-author papers:
- J Hepatocell Carcinoma, 2026 (senior author): Dosimetric Impact and Correction of Lipiodol Deposition on Photon-Beam Radiotherapy for Hepatocellular Carcinoma Using a Novel Simulation Model. PubMed 42148321
- Cancer Med, 2026 (senior author): Efficacy and Safety of Intensity-Modulated Radiotherapy Combined With Regorafenib With or Without Immune Checkpoint Inhibitors as Second-Line Treatment for Advanced Hepatocellular Carcinoma: A Real-World Cohort Study From a Single Center. PubMed 41964212
- Front Immunol, 2025 (senior author): Combined radiation and immune checkpoint inhibitor therapy for metastatic or recurrent hepatocellular carcinoma: a real-world study of 108 patients. PubMed 40831566
- JHEP Rep, 2025 (senior author): Phase II study with sorafenib plus radiotherapy for advanced HCC with portal and/or hepatic vein tumor thrombosis. PubMed 39980754
- J Hepatocell Carcinoma, 2024 (senior author): Radiotherapy with Targeted Therapy or Immune Checkpoint Inhibitors for Hepatocellular Carcinoma with Hepatic Vein and/or Inferior Vena Cava Tumor Thrombi. PubMed 39131509
- Heliyon, 2024 (senior author): Silencing of spindle apparatus coiled-coil protein 1 suppressed the progression of hepatocellular carcinoma through farnesyltransferase-beta and increased drug sensitivity. PubMed 39148981
- Clin Transl Radiat Oncol, 2024 (senior author): Nodal recurrence mapping and clinical target volumes after resection of intrahepatic cholangiocarcinoma or combined hepatocellular-cholangiocarcinoma. PubMed 38425471
- Hepatology, 2021 (first author): Phase 2 Study of Adjuvant Radiotherapy Following Narrow-Margin Hepatectomy in Patients With HCC. PubMed 34097307
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that the papers match this doctor's specialty; this check is automatic.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion